Literature DB >> 9419365

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.

A Lalvani1, R Brookes, R J Wilkinson, A S Malin, A A Pathan, P Andersen, H Dockrell, G Pasvol, A V Hill.   

Abstract

Protective immunity to Mycobacterium tuberculosis is poorly understood, but mounting evidence, at least in animal models, implicates major histocompatibility complex class I-restricted CD8+ T cells as an essential component. By using a highly sensitive assay for single cell interferon gamma release, we screened an array of M. tuberculosis antigen-derived peptides congruent with HLA class I allele-specific motifs. We identified CD8+ T cells specific for epitopes in the early secretory antigenic target 6 during active tuberculosis, after clinical recovery and in healthy contacts. Unrestimulated cells exhibited peptide-specific interferon gamma secretion, whereas lines or clones recognized endogenously processed antigen and showed cytolytic activity. These results provide direct evidence for the involvement of CD8+ cytotoxic T lymphocytes in host defense against M. tuberculosis in humans and support current attempts to generate protective cytotoxic T lymphocyte responses against M. tuberculosis by vaccination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9419365      PMCID: PMC18198          DOI: 10.1073/pnas.95.1.270

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.

Authors:  R J Mazzaccaro; M Gedde; E R Jensen; H M van Santen; H L Ploegh; K L Rock; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro.

Authors:  J Turner; H M Dockrell
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.

Authors:  M J Newport; C M Huxley; S Huston; C M Hawrylowicz; B A Oostra; R Williamson; M Levin
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

4.  Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations.

Authors:  P Krausa; M Brywka; D Savage; K M Hui; M Bunce; J L Ngai; D L Teo; Y W Ong; D Barouch; C E Allsop
Journal:  Tissue Antigens       Date:  1995-04

5.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Authors:  K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; R R Deck; C M DeWitt; I M Orme; S Baldwin; C D'Souza; A Drowart; E Lozes; P Vandenbussche; J P Van Vooren; M A Liu; J B Ulmer
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Vaccination against tuberculosis by DNA injection.

Authors:  R E Tascon; M J Colston; S Ragno; E Stavropoulos; D Gregory; D B Lowrie
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.

Authors:  B Wizel; R A Houghten; K C Parker; J E Coligan; P Church; D M Gordon; W R Ballou; S L Hoffman
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

8.  Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.

Authors:  P Andersen; A B Andersen; A L Sørensen; S Nagai
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

9.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

Authors:  M Harboe; T Oettinger; H G Wiker; I Rosenkrands; P Andersen
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria.

Authors:  M Aidoo; A Lalvani; C E Allsopp; M Plebanski; S J Meisner; P Krausa; M Browning; S Morris-Jones; F Gotch; D A Fidock
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

View more
  114 in total

Review 1.  Partners in crime: co-infections in the developing world.

Authors:  A Pennycook; P Openshaw; T Hussell
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c.

Authors:  Michèl R Klein; Abdulrahman S Hammond; Steve M Smith; Assan Jaye; Pauline T Lukey; Keith P W J McAdam
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  CD8+ T cells provide an immunologic signature of tuberculosis in young children.

Authors:  Christina Lancioni; Melissa Nyendak; Sarah Kiguli; Sarah Zalwango; Tomi Mori; Harriet Mayanja-Kizza; Stephen Balyejusa; Megan Null; Joy Baseke; Deo Mulindwa; Laura Byrd; Gwendolyn Swarbrick; Christine Scott; Denise F Johnson; LaShaunda Malone; Philipa Mudido-Musoke; W Henry Boom; David M Lewinsohn; Deborah A Lewinsohn
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

4.  Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells.

Authors:  E Liebana; A Aranaz; F E Aldwell; J McNair; S D Neill; A J Smyth; J M Pollock
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

5.  Artificial mycobacterial particles for immunization against tuberculosis.

Authors:  L R Lebedev; M Sh Azaev; YuV Tumanov; A A Sizov; A A Il'ychev; S I Tat'kov
Journal:  Dokl Biol Sci       Date:  2002 Nov-Dec

Review 6.  What is Good's syndrome? Immunological abnormalities in patients with thymoma.

Authors:  P Kelleher; S A Misbah
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

7.  HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase.

Authors:  Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

9.  Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis.

Authors:  Margot A Skinner; Natalie Parlane; Allison McCarthy; Bryce M Buddle
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

10.  Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design.

Authors:  Johan Vekemans; Martin O C Ota; Jackson Sillah; Katherine Fielding; Mark R Alderson; Yasir A W Skeiky; Wilfried Dalemans; Keith P W J McAdam; Christian Lienhardt; Arnaud Marchant
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.